mipomersen sodium
301012-CS17
Phase 3 small_molecule completed
Quick answer
mipomersen sodium for Lipid Metabolism, Inborn Errors is a Phase 3 program (small_molecule) at IONIS PHARMACEUTICALS INC with 2 ClinicalTrials.gov record(s).
Program details
- Company
- IONIS PHARMACEUTICALS INC
- Indication
- Lipid Metabolism, Inborn Errors
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed